MEOPA ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 149 | Hemiconvulsion hemiplegia epilepsy syndrome | 1 |
149. Hemiconvulsion hemiplegia epilepsy syndrome
Clinical trials : 25 / Drugs : 35 - (DrugBank : 13) / Drug target genes : 16 - Drug target pathways : 22
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00632528 (ClinicalTrials.gov) | March 2008 | 28/2/2008 | MEOPA to Improve Physical Therapy Results After Multilevel Surgery | Evaluation of the Efficacy of MEOPA Used to Obtain Better ROM Immediately After Multilevel Surgery in Children With Spastic Diplegia, Quadriplegia or Hemiplegia. | Cerebral Palsy;Spastic Diplegia;Quadriplegia;Hemiplegia | Drug: MEOPA;Drug: Medicinal air | Assistance Publique - Hôpitaux de Paris | NULL | Completed | 6 Years | 20 Years | All | 64 | Phase 3 | France |